End-of-day quote
NORDIC GROWTH MARKET
04:30:00 31/01/2024 am IST
|
5-day change
|
1st Jan Change
|
0.117
SEK
|
-2.50%
|
|
-.--%
|
-48.00%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
36.24
|
25.2
|
64.8
|
54.03
|
36.86
|
24.99
|
Enterprise Value (EV)
1 |
37.35
|
21.24
|
66.89
|
52.14
|
36.2
|
29.53
|
P/E ratio
|
-3.84
x
|
-3.99
x
|
-10.3
x
|
-6.73
x
|
-4.07
x
|
-2.81
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3,263
x
|
8.24
x
|
34
x
|
20.9
x
|
44.9
x
|
11.1
x
|
EV / Revenue
|
3,362
x
|
6.94
x
|
35.1
x
|
20.2
x
|
44.1
x
|
13.1
x
|
EV / EBITDA
|
-4.56
x
|
-4.28
x
|
-13.5
x
|
-7.49
x
|
-4.58
x
|
-4.17
x
|
EV / FCF
|
-7.02
x
|
-3.33
x
|
-18.1
x
|
-7.6
x
|
-10.9
x
|
-25.1
x
|
FCF Yield
|
-14.2%
|
-30.1%
|
-5.51%
|
-13.2%
|
-9.18%
|
-3.99%
|
Price to Book
|
27.4
x
|
2.86
x
|
7.33
x
|
6.38
x
|
6.32
x
|
1.73
x
|
Nbr of stocks (in thousands)
|
30,978
|
59,727
|
59,727
|
88,577
|
1,00,699
|
1,11,069
|
Reference price
2 |
1.170
|
0.4220
|
1.085
|
0.6100
|
0.3660
|
0.2250
|
Announcement Date
|
11/04/19
|
15/06/20
|
12/04/21
|
25/05/22
|
04/05/23
|
03/05/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.0111
|
3.061
|
1.908
|
2.582
|
0.82
|
2.259
|
EBITDA
1 |
-8.184
|
-4.966
|
-4.969
|
-6.965
|
-7.9
|
-7.076
|
EBIT
1 |
-9.164
|
-6.072
|
-6.208
|
-7.724
|
-8.475
|
-7.651
|
Operating Margin
|
-82,497.45%
|
-198.4%
|
-325.35%
|
-299.15%
|
-1,033.54%
|
-338.69%
|
Earnings before Tax (EBT)
1 |
-9.431
|
-6.322
|
-6.315
|
-7.8
|
-8.517
|
-8.302
|
Net income
1 |
-9.431
|
-6.322
|
-6.315
|
-7.8
|
-8.517
|
-8.302
|
Net margin
|
-84,905.88%
|
-206.57%
|
-330.94%
|
-302.09%
|
-1,038.66%
|
-367.51%
|
EPS
2 |
-0.3045
|
-0.1059
|
-0.1054
|
-0.0907
|
-0.0900
|
-0.0800
|
Free Cash Flow
1 |
-5.317
|
-6.385
|
-3.686
|
-6.861
|
-3.322
|
-1.177
|
FCF margin
|
-47,862.83%
|
-208.6%
|
-193.17%
|
-265.72%
|
-405.14%
|
-52.12%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/04/19
|
15/06/20
|
12/04/21
|
25/05/22
|
04/05/23
|
03/05/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1.1
|
-
|
2.09
|
-
|
-
|
4.54
|
Net Cash position
1 |
-
|
3.97
|
-
|
1.89
|
0.66
|
-
|
Leverage (Debt/EBITDA)
|
-0.1346
x
|
-
|
-0.42
x
|
-
|
-
|
-0.641
x
|
Free Cash Flow
1 |
-5.32
|
-6.38
|
-3.69
|
-6.86
|
-3.32
|
-1.18
|
ROE (net income / shareholders' equity)
|
-428%
|
-125%
|
-60%
|
-75.3%
|
-119%
|
-82%
|
ROA (Net income/ Total Assets)
|
-71.2%
|
-37.5%
|
-25.6%
|
-34.9%
|
-55.7%
|
-28.3%
|
Assets
1 |
13.24
|
16.86
|
24.66
|
22.35
|
15.29
|
29.29
|
Book Value Per Share
2 |
0.0400
|
0.1500
|
0.1500
|
0.1000
|
0.0600
|
0.1300
|
Cash Flow per Share
2 |
0.0600
|
0.1000
|
0
|
0.0300
|
0.0100
|
0
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/04/19
|
15/06/20
|
12/04/21
|
25/05/22
|
04/05/23
|
03/05/24
|
|
1st Jan change
|
Capi.
|
---|
| -48.00% | 33.88L | | -26.77% | 1.65TCr | | -43.46% | 279.07Cr | | +22.46% | 193.77Cr | | -12.32% | 146.05Cr | | +31.49% | 133.45Cr | | -16.15% | 97Cr | | +1.33% | 79Cr | | -31.07% | 79Cr | | -25.95% | 62Cr |
Medical Diagnostic & Testing Equipment
|